<?xml version="1.0" encoding="UTF-8"?>
<svg xmlns="http://www.w3.org/2000/svg" id="-svg" class="Diagram"  baseProfile="full" prefix="schema:http://schema.org/" preserveAspectRatio="xMidYMid"  version="1.1"><defs><g id="icon-defs"/><g id="marker-defs"><marker id="mea" markerHeight="12" markerWidth="12" orient="auto" preserveAspectRatio="none" refX="12" refY="6" viewBox="0 0 12 12"><g id="g-mea" transform=""><g transform="rotate(180 6 6)"><rect y="5.4" width="2" height="1.2" style="stroke:#fff"/><polygon points="12 11 0 6 12 1" stroke-width="0"/></g></g></marker></g></defs><g id="viewport-20220102145028610" class="svg-pan-zoom_viewport" transform="matrix(0.72 0 0 0.72 96.96 0)" style="transform:matrix(0.72, 0, 0, 0.72, 96.96, 0)"><style>svg.Diagram {font-family: 'Liberation Sans', Arial, sans-serif; }.Diagram path {fill: transparent;stroke: #000;marker-end: url(#mea);}.Diagram symbol path {fill: inherit;stroke: inherit;stroke-width: inherit;marker-end: inherit;}.Diagram rect {fill: #fff;stroke: #000;}.Diagram text {dominant-baseline: central;overflow: hidden;text-anchor: middle;fill: #000;font-size: 12px;}</style><style type="text/css">.Viewport .textContent {
  pointer-events: none;
  stroke-width: 0px;
}

					.Viewport.Icon {
  fill: white;
}

/* Hide the InfoBox */
.Viewport.textContent {
  font-size: 0;
}

.textContent {
  stroke: none;
}

.DataNode {
  stroke-miterlimit: 1;
  pointer-events: auto;
}

.DataNode:hover {
  cursor: pointer;
}

/* TODO should this apply to things other than DataNodes? */
.DataNode.textContent {
  pointer-events: none;
}

.DataNode.Highlighted {
  opacity: 0.6;
  stroke-width: 0px;
}

marker {
  /* this is what should work per the spec
  stroke-dasharray: none; */
  /* but I need to add this to make it work in Safari */
  stroke-dasharray: 9999999999999999999999999;
}

.Citation.Icon {
  fill: none;
  stroke-width: 0px;
}

.Citation.textContent {
  text-align: center;
  vertical-align: top;
  font-size: 7px;
  fill: #999;
  fill-opacity: 1;
  stroke: none;
}</style><g id="WP5035" class="Pathway http___identifiers_org_pw_PW_0000527 Viewport"  name="Name: ACE2 inhibition leads to pulmonary fibrosis Organism: Homo sapiens" ><g class="Pathway http___identifiers_org_pw_PW_0000527 Viewport"><rect   width="1394.6" height="989.75" style="stroke:none"/><g id="f2354" class="Edge"  ><path    d="m1089.2 423.55 144.79 111.1"/></g><g id="pvjsgeneratedidfe191" class="Edge"  ><path    d="m1034.1 676.32" style="marker-end:none"/></g><g id="id1552b68" class="Edge"  ><path    d="m399 316.68" style="marker-end:none"/></g><g id="id15ceadb1" class="Edge"  ><path    d="m1034.1 676.32-217.76 121.2"/></g><g id="id214731c2" class="Edge"  ><path    d="m769.87 822.52-1e-13 112.22"/></g><g id="id479fa4fe" class="Edge"  ><path    d="m843.58 66.65 190.56 119.85"/></g><g id="id4ce306be" class="Edge"  ><path    d="m769.87 559.65h1e-13" style="marker-end:none"/></g><g id="id570aed5e" class="Edge"  ><path    d="m399 211.5" style="marker-end:none"/></g><g id="id7e19e441" class="Edge"  ><path    d="m399 211.5v80.18"/></g><g id="id89311299" class="Edge"  ><path    d="m399 423.55 324.37 373.98"/></g><g id="id977e17f7" class="Edge"  ><path    d="m1034.1 423.55v1e-13" style="marker-end:none"/></g><g id="ida6ac42e8" class="Edge"  ><path    d="m769.87 822.52h-1e-13" style="marker-end:none"/></g><g id="idabad1229" class="Edge"  ><path    d="m1034.1 211.5v187.05"/></g><g id="idb5f28f5a" class="Edge"  ><path    d="m769.87 423.55" style="marker-end:none"/></g><g id="idbc9182bd" class="Edge"  ><path    d="m1234 559.65h-1e-13" style="marker-end:none"/></g><g id="idcc588a5e" class="Edge"  ><path    d="m769.87 423.55v111.1"/></g><g id="idd3210da8" class="Edge"  ><path    d="m843.58 66.65-444.58 119.85"/></g><g id="idd87eb1e" class="Edge"  ><path    d="m843.58 66.65-2e-13 -5e-14" style="marker-end:none"/></g><g id="ide221c0dd" class="Edge"  ><path    d="m769.87 559.65 158.31 91.67"/></g><g id="ide77179d4" class="Edge"  ><path    d="m1034.1 423.55v227.78"/></g><g id="idef7bab3c" class="Edge"  ><path    d="m399 316.68v81.87"/></g><g id="idf1a7869a" class="Edge"  ><path    d="m1034.1 211.5" style="marker-end:none"/></g><g id="idf6043800" class="Edge"  ><path    d="m1234 559.65-93.93 91.67"/></g><g id="a550b" class="Pathway" transform="translate(1143.3 559.65)"  name="Prostaglandin signaling" ><g class="Pathway"><rect   width="181.42" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-90.71" y="-12.5" width="181.42" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(90.71 12.5)"    font-weight="bold"  style="fill:#14961e">Prostaglandin signaling</text></g></g><g id="b2397" class="Pathway" transform="translate(921.46 423.55)"  name="Bradykinin signaling network" ><g class="Pathway"><rect   width="225.36" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-112.68" y="-12.5" width="225.36" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(112.68 12.5)"    font-weight="bold"  style="fill:#14961e">Bradykinin signaling network</text></g></g><g id="b409c" class="Unknown" transform="translate(923.94 398.55)"  name="Bradykinin receptor B1 activation" ><rect   width="220.4" height="25"/><text   transform="translate(110.2 12.5)"    >Bradykinin receptor B1 activation</text></g><g id="b99c0" class="Unknown AOP-Wiki_KE_1496" transform="translate(822.24 651.32)"  name="Increased, secretion of proinflammatory and profibrotic mediators" ><rect   width="423.81" height="25"/><text   transform="translate(211.9 12.5)"    >Increased, secretion of proinflammatory and profibrotic mediators</text></g><g id="ba262" class="Event AOP-Wiki_KE_1172" transform="translate(609.37 534.65)"  name="Increase activation, Nuclear factor kappa B (NF-kB)" ><g class="Event AOP-Wiki_KE_1172"><rect   width="321" height="25"/></g><g ><defs><clipPath ><rect x="-160.5" y="-12.5" width="321" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(160.5,12.5)"    >Increase activation, Nuclear factor kappa B (NF-kB)</text></g></g><g id="c1af7" class="Pathway" transform="translate(228,211.5)"  name="Metabolism of Angiotensinogen to Angiotensins" ><g class="Pathway"><rect   width="342" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-171" y="-12.5" width="342" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(171,12.5)"    font-weight="bold"  style="fill:#14961e">Metabolism of Angiotensinogen to Angiotensins</text></g></g><g id="cf66e" class="Event AOP-Wiki_KE_1115" transform="translate(641.87 398.55)"  name="Increased, Reactive oxygen species" ><g class="Event AOP-Wiki_KE_1115"><rect   width="256" height="25"/></g><g ><defs><clipPath ><rect x="-128" y="-12.5" width="256" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(128,12.5)"    >Increased, Reactive oxygen species</text></g></g><g id="d25dd" class="Pathway" transform="translate(260 316.68)"  name="Renin Angiotensin Aldosterone System" ><g class="Pathway"><rect   width="278" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-139" y="-12.5" width="278" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(139,12.5)"    font-weight="bold"  style="fill:#14961e">Renin Angiotensin Aldosterone System</text></g></g><g id="eb778" class="Unknown AOP-Wiki_KE_1867" transform="translate(923.33 186.5)"  name="Bradykinin system, hyperactivated" ><rect   width="221.61" height="25"/><text   transform="translate(110.81 12.5)"    >Bradykinin system, hyperactivated</text></g><g id="f0a9a" class="Event AOP-Wiki_KE_1740" transform="translate(766.58 41.65)"  name="KE1740: ACE2 inhibition" ><g class="Event AOP-Wiki_KE_1740"><rect   width="154" height="25"/></g><g ><defs><clipPath ><rect x="-77" y="-12.5" width="154" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(77,12.5)"    >KE1740: ACE2 inhibition</text></g></g><g id="f37f8" class="Pathway" transform="translate(705.13 423.55)"  name="Oxidative stress" ><g class="Pathway"><rect   width="129.49" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-64.75" y="-12.5" width="129.49" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(64.75 12.5)"    font-weight="bold"  style="fill:#14961e">Oxidative stress</text></g></g><g id="f5a92" class="Pathway" transform="translate(709.76 559.65)"  name="NF-KB pathway" ><g class="Pathway"><rect   width="120.23" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-60.12" y="-12.5" width="120.23" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(60.12 12.5)"    font-weight="bold"  style="fill:#14961e">NF-KB pathway</text></g></g><g id="c9e7f" class="Event AOP-Wiki_KE_1752" transform="translate(296.5,186.5)"  name="KE1752: Increased Angiotensin II" ><g class="Event AOP-Wiki_KE_1752"><rect   width="205" height="25"/></g><g ><defs><clipPath ><rect x="-102.5" y="-12.5" width="205" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(102.5,12.5)"    >KE1752: Increased Angiotensin II</text></g></g><g id="e9df7" class="Event AOP-Wiki_KE_1743" transform="translate(271 291.68)"  name="KE1743: Increased plasma Angiotensin II" ><g class="Event AOP-Wiki_KE_1743"><rect   width="256" height="25"/></g><g ><defs><clipPath ><rect x="-128" y="-12.5" width="256" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(128,12.5)"    >KE1743: Increased plasma Angiotensin II</text></g></g><g id="ca74c" class="Event AOP-Wiki_KE_68" transform="translate(676.87 797.52)"  name="KE68: Collagen Accumulation" ><g class="Event AOP-Wiki_KE_68"><rect   width="186" height="25"/></g><g ><defs><clipPath ><rect x="-93" y="-12.5" width="186" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(93,12.5)"    >KE68: Collagen Accumulation</text></g></g><g id="a99c1" class="Event AOP-Wiki_KE_1276" transform="translate(695.87 934.75)"  name="KE1276: Lung Fibrosis" ><g class="Event AOP-Wiki_KE_1276"><rect   width="148" height="25"/></g><g ><defs><clipPath ><rect x="-74" y="-12.5" width="148" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(74,12.5)"    >KE1276: Lung Fibrosis</text></g></g><g id="fe190" class="Pathway" transform="translate(598.87 822.52)"  name="Collagen biosynthesis and modifying enzymes" ><g class="Pathway"><rect   width="342" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-171" y="-12.5" width="342" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(171,12.5)"    font-weight="bold"  style="fill:#14961e">Collagen biosynthesis and modifying enzymes</text></g></g><g id="ed7be" class="Edge"  ><path    d="m399 423.55v0.95" style="marker-end:none"/></g><g id="e5b8a" class="Event AOP-Wiki_KE_1851" transform="translate(199.85 398.55)"  name="Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)" ><g class="Event AOP-Wiki_KE_1851"><rect   width="398.29" height="25"/></g><g ><defs><clipPath ><rect x="-199.15" y="-12.5" width="398.29" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(199.15 12.5)"    >Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)</text></g></g><g id="f1d0a" class="Pathway" transform="translate(259 424.5)"  name="Angiotensin II receptor type 1 pathway" ><g class="Pathway"><rect   width="280" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-140" y="-12.5" width="280" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(140,12.5)"    font-weight="bold"  style="fill:#14961e">Angiotensin II receptor type 1 pathway</text></g></g><g id="a18ad" class="Pathway" transform="translate(781.08 66.65)"  name="ACE2 inhibition" ><g class="Pathway"><rect   width="125" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-62.5" y="-12.5" width="125" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(62.5,12.5)"    font-weight="bold"  style="fill:#14961e">ACE2 inhibition</text></g></g><g id="a5a17" class="Edge"  ><path    d="m598.15 411.05h43.73"/></g><g id="d284d" class="Unknown AOP-Wiki_KE_1" transform="translate(1109.9 534.65)"  name="Increased, Prostaglandin E2 secretion" ><rect   width="248.15" height="25"/><text   transform="translate(124.08 12.5)"    >Increased, Prostaglandin E2 secretion</text></g><g id="dce22" class="Pathway" transform="translate(946.51 211.5)"  name="Kinin-Kallikrein Pathway" ><g class="Pathway"><rect   width="175.25" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-87.62" y="-12.5" width="175.25" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(87.62 12.5)"    font-weight="bold"  style="fill:#14961e">Kinin-Kallikrein Pathway</text></g></g><g id="db290" class="Pathway" transform="translate(838.97 676.32)"  name="Overview of proinflammatory and profibrotic mediators" ><g class="Pathway"><rect   width="390.33" height="25" rx="15" ry="15" style="stroke:#14961e"/></g><g ><defs><clipPath ><rect x="-195.16" y="-12.5" width="390.33" height="25" style="stroke:none"/></clipPath></defs><text   transform="translate(195.16 12.5)"    font-weight="bold"  style="fill:#14961e">Overview of proinflammatory and profibrotic mediators</text></g></g></g></g></g></svg>